 | • レポートコード：GIR-107A14785 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トランスサイレチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トランスサイレチンの種類別市場規模（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他）、用途別市場規模（家庭性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トランスサイレチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Alnylam Pharmaceuticals Inc、Arcturus Therapeutics Inc、Ionis Pharmaceuticals Inc、Neurimmune Holding AG、Pfizer Inc、Prothena Corp Plc、Regeneron Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他 ・用途別分析2016年-2026年：家庭性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他 ・トランスサイレチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トランスサイレチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トランスサイレチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トランスサイレチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トランスサイレチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Transthyretin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Transthyretin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Transthyretin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Transthyretin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Market segment by Application can be divided into
Familial Amyloid Neuropathies
Alzheimer’s Disease
Cardomyopathy
Neuropathy
Others
The key market players for global Transthyretin market are listed below:
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Transthyretin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transthyretin, with price, sales, revenue and global market share of Transthyretin from 2019 to 2021.
Chapter 3, the Transthyretin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transthyretin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Transthyretin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Transthyretin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Transthyretin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transthyretin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AG-10
1.2.3 ALN-TTRsc02
1.2.4 CRX-1008
1.2.5 EDE-1307
1.2.6 Inotersen Sodium
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transthyretin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Familial Amyloid Neuropathies
1.3.3 Alzheimer’s Disease
1.3.4 Cardomyopathy
1.3.5 Neuropathy
1.3.6 Others
1.4 Global Transthyretin Market Size & Forecast
1.4.1 Global Transthyretin Sales in Value (2016-2026))
1.4.2 Global Transthyretin Sales in Volume (2016-2026)
1.4.3 Global Transthyretin Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Transthyretin Production Capacity Analysis
1.5.1 Global Transthyretin Total Production Capacity (2016-2026)
1.5.2 Global Transthyretin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transthyretin Market Drivers
1.6.2 Transthyretin Market Restraints
1.6.3 Transthyretin Trends Analysis
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals Inc
2.1.1 Alnylam Pharmaceuticals Inc Details
2.1.2 Alnylam Pharmaceuticals Inc Major Business
2.1.3 Alnylam Pharmaceuticals Inc Transthyretin Product and Services
2.1.4 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Arcturus Therapeutics Inc
2.2.1 Arcturus Therapeutics Inc Details
2.2.2 Arcturus Therapeutics Inc Major Business
2.2.3 Arcturus Therapeutics Inc Transthyretin Product and Services
2.2.4 Arcturus Therapeutics Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ionis Pharmaceuticals Inc
2.3.1 Ionis Pharmaceuticals Inc Details
2.3.2 Ionis Pharmaceuticals Inc Major Business
2.3.3 Ionis Pharmaceuticals Inc Transthyretin Product and Services
2.3.4 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Neurimmune Holding AG
2.4.1 Neurimmune Holding AG Details
2.4.2 Neurimmune Holding AG Major Business
2.4.3 Neurimmune Holding AG Transthyretin Product and Services
2.4.4 Neurimmune Holding AG Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pfizer Inc
2.5.1 Pfizer Inc Details
2.5.2 Pfizer Inc Major Business
2.5.3 Pfizer Inc Transthyretin Product and Services
2.5.4 Pfizer Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Prothena Corp Plc
2.6.1 Prothena Corp Plc Details
2.6.2 Prothena Corp Plc Major Business
2.6.3 Prothena Corp Plc Transthyretin Product and Services
2.6.4 Prothena Corp Plc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Regeneron Pharmaceuticals Inc
2.7.1 Regeneron Pharmaceuticals Inc Details
2.7.2 Regeneron Pharmaceuticals Inc Major Business
2.7.3 Regeneron Pharmaceuticals Inc Transthyretin Product and Services
2.7.4 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Transthyretin Sales by Manufacturer
3.1 Global Transthyretin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Transthyretin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Transthyretin
3.4 Market Concentration Rate
3.4.1 Top 3 Transthyretin Manufacturer Market Share
3.4.2 Top 6 Transthyretin Manufacturer Market Share
3.5 Global Transthyretin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Transthyretin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transthyretin Market Size by Region
4.1.1 Global Transthyretin Sales in Volume by Region (2016-2026)
4.1.2 Global Transthyretin Revenue by Region (2016-2026)
4.2 North America Transthyretin Revenue (2016-2026)
4.3 Europe Transthyretin Revenue (2016-2026)
4.4 Asia-Pacific Transthyretin Revenue (2016-2026)
4.5 South America Transthyretin Revenue (2016-2026)
4.6 Middle East and Africa Transthyretin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Transthyretin Sales in Volume by Type (2016-2026)
5.2 Global Transthyretin Revenue by Type (2016-2026)
5.3 Global Transthyretin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Transthyretin Sales in Volume by Application (2016-2026)
6.2 Global Transthyretin Revenue by Application (2016-2026)
6.3 Global Transthyretin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Transthyretin Sales by Type (2016-2026)
7.2 North America Transthyretin Sales by Application (2016-2026)
7.3 North America Transthyretin Market Size by Country
7.3.1 North America Transthyretin Sales in Volume by Country (2016-2026)
7.3.2 North America Transthyretin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Transthyretin Sales by Type (2016-2026)
8.2 Europe Transthyretin Sales by Application (2016-2026)
8.3 Europe Transthyretin Market Size by Country
8.3.1 Europe Transthyretin Sales in Volume by Country (2016-2026)
8.3.2 Europe Transthyretin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Transthyretin Sales by Type (2016-2026)
9.2 Asia-Pacific Transthyretin Sales by Application (2016-2026)
9.3 Asia-Pacific Transthyretin Market Size by Region
9.3.1 Asia-Pacific Transthyretin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Transthyretin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Transthyretin Sales by Type (2016-2026)
10.2 South America Transthyretin Sales by Application (2016-2026)
10.3 South America Transthyretin Market Size by Country
10.3.1 South America Transthyretin Sales in Volume by Country (2016-2026)
10.3.2 South America Transthyretin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transthyretin Sales by Type (2016-2026)
11.2 Middle East & Africa Transthyretin Sales by Application (2016-2026)
11.3 Middle East & Africa Transthyretin Market Size by Country
11.3.1 Middle East & Africa Transthyretin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Transthyretin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Transthyretin Typical Distributors
12.3 Transthyretin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Transthyretin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Transthyretin Revenue by Application, (USD Million), 2021-2026
Table 3. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Alnylam Pharmaceuticals Inc Major Business
Table 5. Alnylam Pharmaceuticals Inc Transthyretin Product and Services
Table 6. Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Arcturus Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Arcturus Therapeutics Inc Major Business
Table 9. Arcturus Therapeutics Inc Transthyretin Product and Services
Table 10. Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ionis Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 12. Ionis Pharmaceuticals Inc Major Business
Table 13. Ionis Pharmaceuticals Inc Transthyretin Product and Services
Table 14. Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Neurimmune Holding AG Basic Information, Manufacturing Base and Competitors
Table 16. Neurimmune Holding AG Major Business
Table 17. Neurimmune Holding AG Transthyretin Product and Services
Table 18. Neurimmune Holding AG Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc Major Business
Table 21. Pfizer Inc Transthyretin Product and Services
Table 22. Pfizer Inc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Prothena Corp Plc Basic Information, Manufacturing Base and Competitors
Table 24. Prothena Corp Plc Major Business
Table 25. Prothena Corp Plc Transthyretin Product and Services
Table 26. Prothena Corp Plc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 28. Regeneron Pharmaceuticals Inc Major Business
Table 29. Regeneron Pharmaceuticals Inc Transthyretin Product and Services
Table 30. Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Transthyretin Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 32. Global Transthyretin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Transthyretin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Transthyretin Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 35. Head Office and Transthyretin Production Site of Key Manufacturer
Table 36. Transthyretin New Entrant and Capacity Expansion Plans
Table 37. Transthyretin Mergers & Acquisitions in the Past Five Years
Table 38. Global Transthyretin Sales by Region (2016-2021e) & (K Pcs)
Table 39. Global Transthyretin Sales by Region (2021-2026) & (K Pcs)
Table 40. Global Transthyretin Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Transthyretin Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 43. Global Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 44. Global Transthyretin Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Transthyretin Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Transthyretin Price by Type (2016-2021e) & (USD/Pcs)
Table 47. Global Transthyretin Price by Type (2021-2026) & (USD/Pcs)
Table 48. Global Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 49. Global Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 50. Global Transthyretin Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Transthyretin Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Transthyretin Price by Application (2016-2021e) & (USD/Pcs)
Table 53. Global Transthyretin Price by Application (2021-2026) & (USD/Pcs)
Table 54. North America Transthyretin Sales by Country (2016-2021e) & (K Pcs)
Table 55. North America Transthyretin Sales by Country (2021-2026) & (K Pcs)
Table 56. North America Transthyretin Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Transthyretin Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 59. North America Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 60. North America Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 61. North America Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 62. Europe Transthyretin Sales by Country (2016-2021e) & (K Pcs)
Table 63. Europe Transthyretin Sales by Country (2021-2026) & (K Pcs)
Table 64. Europe Transthyretin Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Transthyretin Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 67. Europe Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 68. Europe Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 69. Europe Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Transthyretin Sales by Region (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Transthyretin Sales by Region (2021-2026) & (K Pcs)
Table 72. Asia-Pacific Transthyretin Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Transthyretin Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 77. Asia-Pacific Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 78. South America Transthyretin Sales by Country (2016-2021e) & (K Pcs)
Table 79. South America Transthyretin Sales by Country (2021-2026) & (K Pcs)
Table 80. South America Transthyretin Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Transthyretin Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 83. South America Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 84. South America Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 85. South America Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Transthyretin Sales by Country (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Transthyretin Sales by Country (2021-2026) & (K Pcs)
Table 88. Middle East & Africa Transthyretin Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Transthyretin Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Transthyretin Sales by Type (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Transthyretin Sales by Type (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Transthyretin Sales by Application (2016-2021e) & (K Pcs)
Table 93. Middle East & Africa Transthyretin Sales by Application (2021-2026) & (K Pcs)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Transthyretin Typical Distributors
Table 97. Transthyretin Typical Customers
List of Figures
Figure 1. Transthyretin Picture
Figure 2. Global Transthyretin Sales Market Share by Type in 2020
Figure 3. AG-10
Figure 4. ALN-TTRsc02
Figure 5. CRX-1008
Figure 6. EDE-1307
Figure 7. Inotersen Sodium
Figure 8. Others
Figure 9. Global Transthyretin Sales Market Share by Application in 2020
Figure 10. Familial Amyloid Neuropathies
Figure 11. Alzheimer's Disease
Figure 12. Cardomyopathy
Figure 13. Neuropathy
Figure 14. Others
Figure 15. Global Transthyretin Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Transthyretin Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Transthyretin Sales (2016-2026) & (K Pcs)
Figure 18. Global Transthyretin Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Transthyretin Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Transthyretin Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Transthyretin Market Drivers
Figure 22. Transthyretin Market Restraints
Figure 23. Transthyretin Market Trends
Figure 24. Global Transthyretin Sales Market Share by Manufacturer in 2020
Figure 25. Global Transthyretin Revenue Market Share by Manufacturer in 2020
Figure 26. Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Transthyretin Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Transthyretin Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Transthyretin Sales Market Share by Region (2016-2026)
Figure 30. Global Transthyretin Revenue Market Share by Region (2016-2026)
Figure 31. North America Transthyretin Revenue (2016-2026) & (USD Million)
Figure 32. Europe Transthyretin Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Transthyretin Revenue (2016-2026) & (USD Million)
Figure 34. South America Transthyretin Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Transthyretin Revenue (2016-2026) & (USD Million)
Figure 36. Global Transthyretin Sales Market Share by Type (2016-2026)
Figure 37. Global Transthyretin Revenue Market Share by Type (2016-2026)
Figure 38. Global Transthyretin Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Transthyretin Sales Market Share by Application (2016-2026)
Figure 40. Global Transthyretin Revenue Market Share by Application (2016-2026)
Figure 41. Global Transthyretin Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Transthyretin Sales Market Share by Type (2016-2026)
Figure 43. North America Transthyretin Sales Market Share by Application (2016-2026)
Figure 44. North America Transthyretin Sales Market Share by Country (2016-2026)
Figure 45. North America Transthyretin Revenue Market Share by Country (2016-2026)
Figure 46. United States Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Transthyretin Sales Market Share by Type (2016-2026)
Figure 50. Europe Transthyretin Sales Market Share by Application (2016-2026)
Figure 51. Europe Transthyretin Sales Market Share by Country (2016-2026)
Figure 52. Europe Transthyretin Revenue Market Share by Country (2016-2026)
Figure 53. Germany Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Transthyretin Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Transthyretin Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Transthyretin Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Transthyretin Revenue Market Share by Region (2016-2026)
Figure 62. China Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Transthyretin Sales Market Share by Type (2016-2026)
Figure 69. South America Transthyretin Sales Market Share by Application (2016-2026)
Figure 70. South America Transthyretin Sales Market Share by Country (2016-2026)
Figure 71. South America Transthyretin Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Transthyretin Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Transthyretin Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Transthyretin Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Transthyretin Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Transthyretin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界のアルツハイマー病治療市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界のアミロイドペプチド市場 2021：企業別、地域別、種類・用途別 The Amyloid Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の家族性大腸腺腫症治療市場 2021：企業別、地域別、種類・用途別 The Familial Adenomatous Polyposis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界のヘテロ接合性家族性高コレステロール血症治療薬市場 2021：企業別、地域別、種類・用途別 The Heterozygous Familial Hypercholesterolemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界の視神経障害治療薬市場 2021：企業別、地域別、種類・用途別 The Optic Neuropathy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…